ArticleJournal of chemical information and modeling2025
AbSet: A Standardized Data Set of Antibody Structures for Machine Learning Applications.
Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- AVIDbase: A biologically accurate structural dataset of nanobody-antigen complexes.Protein science : a publication of the Protein Society · 2026Article
- Repertoire-scale antibody structural prediction informs therapeutic design.Science advances · 2026Article
- Fitness Landscape for Antibodies 2: Benchmarking Reveals That Protein AI Models Cannot Yet Consistently Predict Developability Properties.bioRxiv : the preprint server for biology · 2025Article
- Computational Methods in Immunoinformatics: Epitope Discovery and Diagnostic Applications.ACS omega · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Machine learning algorithms have played a fundamental role in the development of therapeutic antibodies by being trained on data sets of sequences and/or structures. However, structural data sets remain limited, especially those that include antibody-antigen complexes. Additionally, many of the available structures are not standardized, and antibody-specific databases often do not provide molecular descriptors that could enhance ML models. To address this gap, we introduce AbSet, a curated dataset comprising over 800,000 antibody structures and corresponding molecular descriptors, including both experimentally determined and in silico-generated antibody-antigen complexes. We systematically retrieved antibody structures from the Protein Data Bank (PDB), applied rigorous standardization protocols, and expanded the dataset through large-scale protein-protein docking to generate structural variants of antibody-antigen interactions. Each model was classified as high, medium, acceptable, or incorrect quality based on structural similarity to reference experimental complexes. This classification enables both the construction of a decoy set of confirmed non-binders and the generation of high-confidence augmented structural data for machine learning applications. AbSet is publicly available via the Zenodo repository, with accompanying scripts hosted on GitHub (https://github.com/SFBBGroup/AbSet.git).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.